PharVision Advisers’s Nabors Industries NBR Stock Holding History

PharVision Advisers’s Portfolio NBR Stock Details NBR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-8,948	Closed	-$486K	–	455
2025 Q4	$486K	Buy	+8,948	New	+$436K	0.25%	45

Other funds holding NBR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

MVP

Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

PharVision Advisers's NBR Position: Q1 2026 in Review

PharVision Advisers sold out of Nabors Industries (NBR) in Q1 2026, closing a stake of 8,948 shares — an estimated $486K sold.

PharVision Advisers first reported a position in NBR in Q4 2025 and held it in 1 quarter. The position peaked at $486K in Q4 2025. 237 funds tracked by Wall St. Rank hold NBR as of Q1 2026.

PharVision Advisers reported no remaining Nabors Industries position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 8,948 Nabors Industries shares in Q1 2026, an estimated $486K.
PharVision Advisers first reported a position in Nabors Industries in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Nabors Industries position peaked at $486K in Q4 2025.
237 funds tracked by Wall St. Rank held Nabors Industries as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.